Skip navigation
Por favor, use este identificador para citar o enlazar este ítem: http://repositorio.unb.br/handle/10482/40462
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
ARTIGO_CompreensiveSystematicReview.pdf1,79 MBAdobe PDFVisualizar/Abrir
Título : A comprehensive systematic review of leishmaniasis in patients undergoing drug-induced immunosuppression for the treatment of dermatological, rheumatological and gastroenterological diseases
Autor : Kurizky, Patricia Shu
Marianelli, Fernanda Ferraço
Cesetti, Mariana Vicente
Damiani, Giovanni
Sampaio, Raimunda Nonata Ribeiro
Gonçalves, Lais Mitsue Tanaka
Sousa, Carlos Augusto Felipe de
Martins, Sofia Sales
Vernal, Sebastian
Mota, Licia Maria Henrique da
Gomes, Ciro Martins
metadata.dc.identifier.orcid: http://orcid.org/0000-0002-3069-6884
Assunto:: Imunossupressão
Leishmaniose
Revisão sistemática
Tratamento
Fecha de publicación : 2020
Editorial : Instituto de Medicina Tropical
Citación : KURIZKY, Patrícia Shu et al. A comprehensive systematic review of leishmaniasis in patients undergoing drug-induced immunosuppression for the treatment of dermatological, rheumatological and gastroenterological diseases. Revista do Instituto de Medicina Tropical de São Paulo, São Paulo, v. 62, e28, 2020. DOI: https://doi.org/10.1590/s1678-9946202062028. Disponível em: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652020000100217&lng=en&nrm=iso. Acesso em: 05 abr. 2021.
Abstract: Immunosuppression is an important risk factor for leishmaniasis. We assessed the clinical profile, geographic distribution and prevalence of leishmaniasis in patients undergoing immunosuppressive therapy for dermatological, rheumatological or gastroenterological autoimmune diseases. We identified relevant studies in PubMed, EMBASE, Scopus, Web of Science and LILACS on July 3rd, 2018. We included articles that reported at least one case of leishmaniasis in patients undergoing immunosuppressive treatment for dermatological, rheumatological or gastroenterological diseases. Our protocol was registered in PROSPERO (CRD42018103050). We assessed the quality of the included studies with the Joanna Briggs Institute Critical Appraisal Tool. After the removal of duplicates, 5,431 articles were collected and screened. We included 138 articles; the prevalence of leishmaniasis in six methodologically similar studies varied from three to 1,282 cases per 100,000 patients using anti-TNFα drugs, but the results were significantly heterogeneous . Leishmaniasis in patients treated with immunosuppressive drugs is a health problem mostly reported in European countries bordering the Mediterranean Sea; sporadic activities, such as travelling, seem not to be associated with a significant risk of leishmaniasis, although effective control measures must always be observed.
metadata.dc.description.unidade: Faculdade de Medicina (FMD)
Licença:: (CC BY NC) - This is an open-access article distributed under the terms of the Creative Commons Attribution License.
DOI: https://doi.org/10.1590/s1678-9946202062028
Aparece en las colecciones: Artigos publicados em periódicos e afins

Mostrar el registro Dublin Core completo del ítem " class="statisticsLink btn btn-primary" href="/jspui/handle/10482/40462/statistics">



Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.